✉ info@591daili.com☎ +86-18553102138
📞 WhatsAppEnglish
圣和化工
首页 › 产品目录 › 格卡瑞韦

格卡瑞韦

CAS 1365970-03-1C38H46F4N6O9SMW 838.9

格卡瑞韦,CAS 登记号 1365970-03-1,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于有机化学品。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。

规格参数

CAS号1365970-03-1
分子式C38H46F4N6O9S
分子量838.9
LogP4.6
纯度按批次COA提供(不公开发布)
包装按订单/批次确认(不公开发布)
应用领域有机化学品
类别有机化学品

用途与场景

有机化学品

包装与供货

包装规格按订单/批次确认(不公开发布)
纯度规格按批次COA提供(不公开发布)
储存条件密封、阴凉干燥处保存
供货周期现货/按订单安排

文件与支持

每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。

常见问题

在哪里能查到 格卡瑞韦 的 CAS 号?

本页已列出 格卡瑞韦 的 CAS 号:1365970-03-1,可与随货 COA 核对。

可以提供哪些规格和包装?

常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。

格卡瑞韦 一般用在什么产品里?

主要涉及有机化学品。

下单流程是怎样的?

来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。

PubChem 公开数据

Description

Glecaprevir · CAS 1365970-03-1 · C38H46F4N6O9S. UNII K6BUU8J72P. Solubility: <0.1 to 0.3 mg/mL.

Identification

CAS Registry Number1365970-03-1
PubChem CID66828839
Molecular formulaC38H46F4N6O9S
IUPAC name(1R,14E,18R,22R,26S,29S)-26-tert-butyl-N-[(1R,2R)-2-(difluoromethyl)-1-[(1-methylcyclopropyl)sulfonylcarbamoyl]cyclopropyl]-13,13-difluoro-24,27-dioxo-2,17,23-trioxa-4,11,25,28-tetrazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3,5,7,9,11,14-hexaene-29-carboxamide
UNII (FDA)K6BUU8J72P

Computed Descriptors

Molecular Weight838.9
XLogP34.6
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count15
Rotatable Bond Count7
Exact Mass838.29831089
Monoisotopic Mass838.29831089
Topological Polar Surface Area204
Heavy Atom Count58
Formal Charge0

Physical & Chemical Properties

Solubility<0.1 to 0.3 mg/mL

Documented Uses

  • Indicated for the treatment of adult patients with acute and chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A). MAVYRET is also indicated for the treatment of adult patients with HCV genotype 1 infection, who previously have been treated with a regimen containing an HCV NS5A inhibitor or an NS3/4A protease inhibitor (PI), but not both.
  • Breast Feeding; Lactation; Milk, Human; Antiviral Agents; Protease Inhibitors
  • Avoid St. John's Wort. Co-administration may lead to decreased serum concentrations of glecaprevir.
  • Established Pharmacologic Class [EPC] - Hepatitis C Virus NS3/4A Protease Inhibitor
  • Mechanisms of Action [MoA] - HCV NS3/4A Protease Inhibitors
  • Mechanisms of Action [MoA] - P-Glycoprotein Inhibitors

Synonyms

Glecaprevir; 1365970-03-1; ABT-493; Maviret; K6BUU8J72P; A-1282576.0; A-1282576; A-12825760; DTXSID901027945; glecaprevirum; RefChem:663069; DTXCID101513512; Glecaprevir [USAN]; BDBM50573891; UNII-K6BUU8J72P; MFCD30533436

Frequently Asked Questions

What are the CAS number and molecular formula of Glecaprevir?

CAS 1365970-03-1; molecular formula C38H46F4N6O9S; molecular weight — g/mol.

What other names is Glecaprevir known by?

Glecaprevir, 1365970-03-1, ABT-493, Maviret, K6BUU8J72P, A-1282576.0.

What are the key physical properties of Glecaprevir?

Solubility: <0.1 to 0.3 mg/mL.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

同类推荐

获取 格卡瑞韦 报价

供应商:济南圣和化工有限公司 · 一个工作日内回复。

邮件询价 WhatsApp
鲁ICP备19031700号-1